SIM
REGN icon

SSI Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

SSI Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-627
Closed -$225K – 393
2014
Q3 		$225K Sell
627
-1,105
-64% -$370K 0.02% 349
2014
Q2 		$489K Buy
1,732
+340
+24% +$101K 0.05% 232
2014
Q1 		$419K Sell
1,392
-1,612
-54% -$497K 0.04% 272
2013
Q4 		$827K Sell
3,004
-4
-0.1% -$1.15K 0.07% 253
2013
Q3 		$945K Buy
3,008
+1,896
+171% +$499K 0.09% 219
2013
Q2 		$250K Buy
+1,112
New +$259K 0.02% 370

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SSI Investment Management's REGN Position: Q4 2014 in Review

SSI Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2014, closing a stake of 627 shares — an estimated $225K sold.

SSI Investment Management first reported a position in REGN in Q2 2013 and held it in 6 quarters. The position peaked at $945K in Q3 2013. 512 funds tracked by Wall St. Rank hold REGN as of Q4 2014.

  • SSI Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • SSI Investment Management sold 627 Regeneron Pharmaceuticals shares in Q4 2014, an estimated $225K.
  • SSI Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • SSI Investment Management's Regeneron Pharmaceuticals position peaked at $945K in Q3 2013.
  • 512 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2014.

Based on SSI Investment Management's 13F filing for Q4 2014, filed 11 Feb 2015.